CPG

Hypercalcemia

PUBLISHED: 1998	REVISED:January 2008
TOPIC: Endocrine	SCOPE: Laboratory investigation
ABSTRACT: The estimated incidence of hypercalcemia due to primary hyperparathyroidism and due to malignancy are 250 cases per million and 150 cases per million respectively. This guideline recommends tests for the initial endocrine investigation of hypercalcemia.
TARGET POPULATION: Patients with signs or symptoms of hypercalcemia
EXCLUSIONS: None specified

Summary: Hypercalcemia

Guideline: Hypercalcemia

Working Group Membership

A multi-disciplinary team comprised of:

General Practitioners
Pathologists
Endocrinologists
Clinical Biochemists
Laboratory technologists
Member of the public